Stantec Inc · TSX:STN
Stantec — Q3 2026 Earnings Presentation
14 slides from Stantec's earnings presentation, Nov 13, 2026
Slide 1: Q3 2026 Results Presentation
Q3 2026 November 13, 2026 Results Presentation
Slide 2: Cautionary statement
Cautionary statement This presentation contains non-IFRS and other financial measures and forward-looking statements, including a discussion of our business targets, expectations, and outlook. We caution readers not to place undue reliance on our forward- looking statements since a number of factors
Slide 3: Third Quarter 2026 Results
Third Quarter 2026 Results Q3 2026 Net Revenue Profile $1.9B 9.4% Global Net revenue increase* 25% Organic Growth1 $377M 16.6% 5.3% Adjusted EBITDA increase* US 20.2% 120 bps 52% Acquisition Growth1 Adjusted EBITDA margin increase* 2.6% $1.89 23.5% Canada Adjusted EPS increase* 23% * Compared to Q3
Slide 4: United States
United States $millions, unless otherwise stated $888 $985 4.9% Organic Growth 10.9% 4.4% Net revenue Acquisition growth Q3 2025 Q3 2026 Q3 2026 Highlights • Page contributed double-digit growth in net revenue, particularly in Buildings. • Strong organic net revenue growth in Water driven by continu
Slide 5: Canada
Canada $millions, unless otherwise stated $416 $400 4.1% Organic Growth 4.1% Net revenue Q3 2025 Q3 2026 Q3 2026 Highlights • Double-digit organic net revenue growth in Water was driven by biosolids projects and continued momentum on wastewater solution projects. • Energy & Resources achieved double
Slide 6: Global
Global $millions, unless otherwise stated $418 $464 7.5% Organic Growth 11.0% 1.1% Net revenue Acquisition growth Q3 2025 Q3 2026 Q3 2026 Highlights • Industry-leading Water business delivered robust double-digit organic growth, led by increased delivery under long-term framework programs in the UK
Slide 7: Q3 2026 Financial Performance
Q3 2026 Financial Performance Vito Culmone Executive Vice President and Chief Financial Officer 7
Slide 8: Q3 2026 Financial results
Q3 2026 Financial results $millions, unless otherwise stated Gross and Project margin Adjusted EBITDA and Adjusted net revenue and % of NR margin as % of NR1 earnings per share1 $2,353 $2,141 $1,865 55.0% $1,705 54.4% $1,025 $928 20.2% 19.0% $1.89 $377 $323 $1.53 Q3 2025 Q3 2026 Q3 2025 Q3 2026 Q3 2
Slide 9: Cash flow, liquidity and capital resources
Cash flow, liquidity and capital resources $millions, unless otherwise stated Operating Capital returned Days sales outstanding cash flow to shareholders Target < 75 days 75 76 73 73 74 $551 69 $509 $175 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Net debt to adjusted EBITDA1 $68 $75 $83 Target
Slide 10: Backlog, Major Projects & Outlook
Backlog, Major Projects & Outlook Susan Reisbord President and Chief Executive Officer 10
Slide 11: Backlog
Backlog $billions, unless otherwise stated $9.2 $8.2 $2.0 9.9% $1.6 Year-Over-Year Organic Growth $5.4 $4.9 11.6% $1.7 $1.8 Global United States Q3 2025 Q3 2026 Canada Arthur J.E. Child Comprehensive Cancer Centre 11 Calgary, AB, Canada
Slide 12: Recent major project awards
Recent major project awards Stantec’s Water team was selected by Stantec’s Buildings team was selected Stantec was selected by England’s the City of Toronto to provide design by a global technology company to Environment Agency to support a and construction administration design a data center facili
Slide 13: 2026 Financial targets
2026 Financial targets 2026 Annual Revised Range targets Net revenue growth 8.5% to 11.5% 9.0% to 11.0% Adjusted EBITDA as % of net revenue1 17.8% to 18.3% 18.3% to 18.5% Adjusted net income as % of net revenue1 at or above 9.5% at or above 9.8% Adjusted EPS growth1 15% to 18% 17% to 19% Adjusted RO
Slide 14: Questions
Questions Ottawa, ON, Canada 14